CHICAGO -- Omitting lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy did not compromise ...

Please provide your email address to receive an email when new articles are posted on . Extended lymphadenectomy did not improve outcomes in localized muscle-invasive bladder cancer vs. standard ...

March 11, 2010 —Systematic removal of pelvic as well as para-aortic lymph nodes may improve survival time vs pelvic lymphadenectomy alone in patients at medium to high risk for endometrial cancer ...

CHICAGO — Patients with advanced ovarian cancer who undergo a complete resection need not also undergo systematic lymphadenectomy because it has no effect on progression-free survival (PFS) or overall ...

Researchers found that adding retroperitoneal lymphadenectomy to cytoreductive surgery did not improve survival among patients with advanced ovarian cancer. The addition of retroperitoneal ...

Fluorescence-guided lymphadenectomy after neoadjuvant chemotherapy was linked to improved survival in gastric cancer. It was also significantly associated with more retrieved lymph nodes. The 3-year ...

To evaluate the therapeutic benefit of lymphadenectomy and adjuvant therapy, in particular chemotherapy, we retrospectively analysed survival rates and patterns of recurrence of endometrioid ...

Primary surgery followed by platinum/taxane-based chemotherapy is the standard therapy in advanced ovarian cancer. The prognostic role of complete debulking has been well described; however, the ...

The role of lymphadenectomy has been studied in both the localized and advanced settings over the past few decades, with a strong suggestion of no therapeutic benefit for patients with cT1-2N0M0 and ...

Regional lymphadenectomy, with both its diagnostic and therapeutic roles, serves as an integral component of the management of many malignancies. Extended pelvic lymph node dissection (LND) is the ...

Gastrectomy with D2 lymphadenectomy is the standard treatment for curable gastric cancer in eastern Asia. Whether the addition of para-aortic nodal dissection (PAND) to D2 lymphadenectomy for stage T2 ...